By Can Celik (May 22, 2018) -- A settlement by Endo Pharmaceuticals with Impax Laboratories didn't violate antitrust law because “the evidence proves that the Endo-Impax Settlement was, on balance, procompetitive,” a judge ruled on Friday in dismissing a complaint by the Federal Trade Commission....